A61K 38/44
Oxidoreductases
Official title: Oxidoreductases (1)
A61K38/44 (Oxidoreductases) appears on 900 US grants and 1,601 published applications in this corpus.
Search patents in A61K- Granted patents
- 900
- Published applications
- 1,601
- Assignees
- 787
- Inventors
- 2,665
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 5 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 12 | 0 |
| 1991 | 14 | 0 |
| 1992 | 19 | 0 |
| 1993 | 11 | 0 |
| 1994 | 10 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 12 | 0 |
| 1998 | 21 | 0 |
| 1999 | 16 | 0 |
| 2000 | 11 | 0 |
| 2001 | 16 | 5 |
| 2002 | 12 | 31 |
| 2003 | 17 | 38 |
| 2004 | 14 | 43 |
| 2005 | 11 | 31 |
| 2006 | 11 | 42 |
| 2007 | 16 | 47 |
| 2008 | 14 | 45 |
| 2009 | 11 | 42 |
| 2010 | 15 | 43 |
| 2011 | 16 | 67 |
| 2012 | 28 | 35 |
| 2013 | 28 | 81 |
| 2014 | 28 | 79 |
| 2015 | 30 | 75 |
| 2016 | 52 | 91 |
| 2017 | 42 | 80 |
| 2018 | 47 | 78 |
| 2019 | 45 | 68 |
| 2020 | 43 | 82 |
| 2021 | 36 | 78 |
| 2022 | 36 | 87 |
| 2023 | 34 | 95 |
| 2024 | 42 | 76 |
| 2025 | 47 | 97 |
| 2026 | 34 | 65 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Treatment of pathogen infections formulations and methods for use25 Aug 2026US 12,714,734 B2
- Method for preparing polyethylene glycol-modified urate oxidase25 Aug 2026US 12,714,741 B2Hangzhou Grand Biologic Pharmaceutical Inc.
- Gout flare prevention methods using IL-1β blockers25 Aug 2026US 12,715,915 B2
- Superoxide dismutase-loaded porous polymersomes as highly efficient antioxidant nanoparticles11 Aug 2026US 12,702,699 B2The Trustees of the University of Pennsylvania
- Core-shell microneedle devices and uses thereof4 Aug 2026US 12,697,474 B2North Carolina State University
- Perfluorocarbon compositions, systems, and methods for ischemic, inflammatory, infectuous, transplant, and other medical conditions8 Oct 2026US 2026/0306422 A1
- Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers8 Oct 2026US 2026/0306589 A1Goa Therapeutics Corporation
- Extracellular vesicles comprising 15-lipoxygenase1 Oct 2026US 2026/0295018 A1Aston University
- Uses of super-oxide dismutase supplements1 Oct 2026US 2026/0295019 A1
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Device for priming for improved adherence of gels to substrates1,210US 5,749,968 AFocal, Inc. · 1998
- Drug-delivering composite structures814US 9,446,226 B2Ramot at Tel-Aviv University Ltd. · 2016
- Gels for encapsulation of biological materials587US 5,858,746 ABoard of Regents, The University of Texas System · 1999
- Gels for encapsulation of biological materials331US 5,529,914 ABoard of Regents, The Univeristy of Texas System · 1996